Inventor
G. Davis Harris, Jr.
Inventor
San Francisco, CA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds6%
C07KPeptides4%
C07HSugars2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,807,9363,6-dichlorosalicylic acid compounds and related synthetic processes202010,519,0923,6-dichlorosalicylic acid compounds and related synthetic processes20199,982,020Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses20189,856,201'3,6-dichlorosalicylic acid compounds and related synthetic processes'20189,133,228'Guanidinyl-substituted polyamides useful for treating human papilloma virus'20158,106,197'Aminoheteroaryl compounds as protein kinase inhibitors'20127,230,098'Aminoheteroaryl compounds as protein kinase inhibitors'20077,186,832'Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors'20077,157,460'Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors'20077,071,332'Indolinone derivatives as protein kinase/phosphatase inhibitors'20066,750,240'Methods of using bis-indolylquinones'20046,706,709'Indolinone derivatives as protein kinase/phosphatase inhibitors'20046,689,806'Indolinone compounds as kinase inhibitors'20046,660,763'Bis-indolylquinone compounds'20036,376,529'Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof'20026,239,161'Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions'20016,110,957'Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom'20006,090,838'Methods and compositions for inhibition of adaptor protein/tyrosine kinase interactions'20006,080,772'Thiazole compounds and methods of modulating signal transduction'20005,786,488'Synthetic methods for the preparation of indolyquinones'19985,780,496'Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2007Patents assigned to SUGEN INC (14)· patent assignee history
1998–2006Based in San Francisco, CA, US· patent location history
2007–2020Based in Chesterfield, MO, US· patent location history
2012Patents assigned to BHUMRALKAR DILIP (1)· patent assignee history
2015–2018Patents assigned to NANOVIR LLC (2)· patent assignee history
2015–2018Patents assigned to UNIV MISSOURI (2)· patent assignee history
2018–2020Patents assigned to MONSANTO TECHNOLOGY LLC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SUGEN INC | 14 | 1998–2007 |
| MONSANTO TECHNOLOGY LLC | 3 | 2018–2020 |
| NANOVIR LLC | 2 | 2015–2018 |
| UNIV MISSOURI | 2 | 2015–2018 |
| BHUMRALKAR DILIP | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 12 | 1998–2006 |
| Chesterfield, MO, US | 9 | 2007–2020 |